Featured publications

• Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models

  Singh, S; Wang, YF; Sircar, A; Jindal, U; Srour, N;

  (...)

  Alinari, L; Peterson, BR; Epperla, N; Jain, N; Sehgal, L.

  See complete list of authors

  Reference:

  Biomark Res 2026.

• Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4.5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the

  Dreyling, M; Doorduijn, J; Giné, E; Jerkeman, M; Walewski, J;

  (...)

  Schmidt, C; Unterhalt, M; Tix, T; Ladetto, M; Hoster, E.

  See complete list of authors

  Reference:

  LANCET 2026.

• The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma

  De Bolos, Anna; Carreras-Caballe, Maria; Sureda-Gomez, Marta; Rodriguez, Marta-Leonor; Charalampopoulou, Stella;

  (...)

  Martin-Subero, Jose, I; Campo, Elias; Reverter, David; Villanueva, Josep; Amador, Virginia.

  See complete list of authors

  Reference:

  Blood Cancer Journal 2025.

• SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features

  Sureda-Gomez, Marta; Iaccarino, Ingram; De Bolos, Anna; Meyer, Mieke; Balsas, Patricia;

  (...)

  Leoncini, Lorenzo; Campo, Elias; Siebert, Reiner; Amador, Virginia; Klapper, Wolfram.

  See complete list of authors

  Reference:

  BLOOD 2024.

• SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma

  Morsy, MHA; Lilienthal, I; Lord, M; Merrien, M; Wasik, AM;

  (...)

  Taylor, IA; Christensson, B; Campo, E; Herold, N; Sander, B.

  See complete list of authors

  Reference:

  BLOOD 2024.

• SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma

  De Bolòs, A; Sureda-Gómez, M; Carreras-Caballé, M; Rodríguez, ML; Clot, G;

  Beà, S; Giné, E; Campo, E; Balsas, P; Amador, V.

  Reference:

  Scientific Reports 2024.

• Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma

  Sureda-Gomez, Marta; Balsas, Patricia; Rodriguez, Marta-Leonor; Nadeu, Ferran; De Bolos, Anna;

  (...)

  Jares, Pedro; Martin-Subero, Jose, I; Bea, Silvia; Campo, Elias; Amador, Virginia.

  See complete list of authors

  Reference:

  LEUKEMIA 2023.

• SOX11, CD70 and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma

  Balsas, Patricia; Veloza, Luis; Clot, Guillem; Sureda-Gomez, Marta; Rodriguez, Marta-Leonor;

  (...)

  Engel, Pablo; Quintanilla-Martinez, Leticia; Klapper, Wolfram; Campo, Elias; Amador, Virginia.

  See complete list of authors

  Reference:

  BLOOD 2021.

• Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death

  Domostegui, Ana; Peddigari, Suresh; Mercer, Carol A; Iannizzotto, Flavia; Rodriguez, Marta L;

  (...)

  Kang, Jian; Gentilella, Antonio; Pearson, Richard B; Thomas, George; Pelletier, Joffrey.

  See complete list of authors

  Reference:

  BLOOD 2021.

• Increased Tumor Angiogenesis in SOX11-positive Mantle Cell Lymphoma

  Petrakis, Georgios; Veloza, Luis; Clot, Guillem; Gine, Eva; Gonzalez-Farre, Blanca;

  (...)

  Martinez, Antonio; Lopez-Guillermo, Armando; Amador, Virginia; Ribera-Cortada, Inmaculada; Campo, Elias.

  See complete list of authors

  Reference:

  HISTOPATHOLOGY 2019.